Skip to main content
Move the World.
New Evidence Suggests Viruses May Trigger Alzheimer’s
An artist rendering of amyloid plaques breaking connections between neurons.Credit: NIH

Two new studies suggest that viruses may play a key role in causing Alzheimer's disease, triggering an immune overreaction in the brain that gradually leads to dementia and death. Old viruses tend to migrate to the brain as we age, and new research suggests that sometimes the brain's immune system freaks out, triggering a flood of "plaques" that trap, kill, or slow down the virus. But these plaques are also toxic to human brain cells, and too much can build up and destroy brain function.

This theory might clear up a lot of conflicting research about how Alzheimer's works, and perhaps explain the persistent failure of Alzheimer's drug development. Rather than merely trying to remove the plaques or stop their production, researchers are now hoping that antiviral treatments could stop the underlying infection in the early stages of the disease.

The Discovery

The idea that viruses cause Alzheimer's has long been dismissed as a fringe theory, and scientists only stumbled on the viral connection by accident. "Viruses were the last thing we were looking for," Dr. Joel Dudley of the Icahn School of Medicine told NPR. Instead, they were looking for genes that were different in the brains of Alzheimer's patients, hoping to find targets for new drugs.

Surprisingly, the biggest discoveries weren't in genes for brain function but in ones that help the immune system defend against viruses. Dudley's team took the hint and started searching for viral infections in the brains of Alzheimer's patients. They found levels of two types of herpesvirus that were twice as high in Alzheimer's patients as in healthy brains. Almost everyone carries these viruses (HHV-6 and HHV-7), which cause a minor childhood rash called roseola, but in Alzheimer's patients, they have migrated to the brain and "woken up" after decades of dormancy.

This discovery didn't prove that the viruses were at fault—they could have just been opportunistic infections, exploiting a weakened brain. But researchers also found that the viruses were interacting with the human genes known to increase the risk of Alzheimer's. That was a strong clue the infections weren't just bystanders.

The Experiment

Independently, a team at Harvard was planning a controlled experiment with another common herpesvirus, HSV-1, which causes cold sores. Tipped off by the Icahn team, they added HHV-6 to the trial. They found that mouse brains infected with these viruses produced a flood of amyloid-beta protein, as did "mini-brains" grown from human cells in a petri dish. This protein is what accumulates into the plaques clogging the brains of Alzheimer's patients, which most scientists believe are responsible for the disease.

Scientists used to think that amyloid-beta was just a waste product, but these researchers had previously found evidence that amyloid-beta is actually part of the brain's ancient immune system. And, in both the mice and the mini-brains, higher amyloid-beta levels helped fight off the infection by forming a sticky "nano-net" that trapped or killed the viruses.

But for some reason (probably related to both genetics and lifestyle), this defense goes haywire in Alzheimer's patients, flooding the brain with too much protein and forming the plaques that cause dementia. As one of the authors summed it up to Gizmodo, "The seeding of amyloid is what causes the deposition of plaque—and herpesviruses and other microbes can rapidly seed amyloid-beta."

The Upshot

The pipeline for new Alzheimer's drugs is slowly running dry, with fewer promising drugs in development each year. Several drugs have been found that can break up plaques and reduce levels of amyloid-beta in the brain, but for the most part, this hasn't translated into better cognitive performance or longer life. One recent drug trial seems to buck this trend, but the results are confusing—improvements in memory and cognition only happened at extremely high doses, and smaller reductions in amyloid actually seemed to accelerate patients' decline.

But the immune overreaction theory could tie together various strands of Alzheimer's research, including genetics, lifestyle, and the wildcard of infection. It could explain why it's so hard to predict who will develop Alzheimer's, and it might explain why reducing protein levels either doesn't stop the disease or has inconsistent results. If the underlying infection is still running rampant in the brain, reducing amyloid-beta could make matters worse, or it could just make things seem better in the short-run, the way that eliminating a fever can make you feel better while making the infection worse.

One of the lingering questions about this theory is what causes old viruses to suddenly go nuts when people start to enter old age. But whatever the reason, it might not matter too much when it comes to treatment, and researchers are hopeful that this theory will open up a whole new class of drugs and preventative therapies. Trials are being planned to test antiviral drugs on early-stage Alzheimer's patients to try to cool down infections that might be driving inflammation and plaque formation, and other possible treatments include vaccines or drugs that could moderate the brain's immune response to infection.

More About

Future of Food
Inside the World of Gourmet Lab Meat
Inside the World of Gourmet Lab Meat
Watch Now
Future of Food
Inside the World of Gourmet Lab Meat
A future of eating meat without ethical or environmental implications is more real than ever before. But will people eat it food grown in a lab?
Watch Now

A future of eating meat without ethical or environmental implications is more real than ever before. While plant-based alternatives are growing in popularity, the real black horse with game-changing potential seems to be actual meat… grown in science labs. The question at this point is not whether this approach is viable or scalable, but simply: will people want to eat it?

Dispatches
Paige and the Virus Hunter
Paige and the Virus Hunter
Dispatches
Paige and the Virus Hunter
Drugs couldn’t stop her infection — so she asked Ben Chan to get her a virus, instead.
By Kaitlin Ugolik

Drugs couldn’t stop her infection — so she asked Ben Chan to get her a virus, instead.

Trailer
Introducing Freethink
Introducing Freethink
Watch Now
Trailer
Introducing Freethink
We’re reimagining media for a generation that’s changing the world.
Watch Now

The world is changing. Fast. And it’s changing because people are changing it. People with new ideas and new perspectives. People who aren’t satisfied with the status quo and aren’t afraid to think differently. At Freethink we’re building a movement. Of rebels, hackers, pioneers, idealists, engineers, tinkerers, scientists, geeks, nerds, influencers, outcasts, artists, activists, do-gooders, disruptors, troublemakers, peacemakers, skeptics, challengers, risk takers. And you. We’re reimagining media for a generation…

Coded
How an Exiled Cryptographer is Protecting Journalists in His Native Ethiopia
How an Exiled Cryptographer is Protecting Journalists in His Native Ethiopia
Watch Now
Coded
How an Exiled Cryptographer is Protecting Journalists in His Native Ethiopia
An exiled blogger teaches journalists in his native Ethiopia how to avoid capture
Watch Now

In Ethiopia, the main prison is divided into eight zones. Many refer to the rest of the country as “Zone 9.” But Endalk Chala is fighting back. Chala moonlights as an encryption expert, helping bloggers in his native Ethiopia escape capture and torture.

Coded
WATCH: Trailer for Our New Show, Coded
WATCH: Trailer for Our New Show, Coded
Coded
WATCH: Trailer for Our New Show, Coded
Meet the programmers on the frontlines of the war over security and privacy.
By Mike Riggs

Meet the programmers on the frontlines of the war over security and privacy.

This week in ideas: How VR changes our dreams, a stem cell miracle, and the shoes...
This week in ideas: How VR changes our dreams, a stem cell miracle, and the shoes of the future
This week in ideas: How VR changes our dreams, a stem cell miracle, and the shoes...
Virtual reality users experience more lucid dreams, a paralyzed man gets movement back, and self-lacing shoes. These are our favorite…
By Mike Riggs

Virtual reality users experience more lucid dreams, a paralyzed man gets movement back, and self-lacing shoes. These are our favorite stories this week.

Superhuman
Meet the Paralyzed Man Who Can Walk Again
Meet the Paralyzed Man Who Can Walk Again
Superhuman
Meet the Paralyzed Man Who Can Walk Again
Robert is paralyzed from the chest down. But now a robotic exoskeleton is giving him what he calls "a second…
By Mike Riggs

Robert is paralyzed from the chest down. But now a robotic exoskeleton is giving him what he calls "a second chance at life."

Superhuman
Everything You Wanted to Know About the World's Most Advanced Bionic Arm
Everything You Wanted to Know About the World's Most Advanced Bionic Arm
Superhuman
Everything You Wanted to Know About the World's Most Advanced Bionic Arm
A fascinating interview with Michael P. McLoughlin, the chief engineer of research and exploratory development at Johns Hopkins Applied Physics…
By Mike Riggs

A fascinating interview with Michael P. McLoughlin, the chief engineer of research and exploratory development at Johns Hopkins Applied Physics Lab.